Skip to main content

Find Clinical Trials

Home
Conditions
Glomerulonephritis

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

73 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Completed

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

NCT03832114

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
Locations: Novartis Investigative Site Iowa City, Iowa, United States

Novartis Investigative Site Montpellier, France

Novartis Investigative Site Paris, France

Novartis Investigative Site Essen, Germany

View Trial Details

Completed

Adrenocorticotropic Hormone in Membranous Nephropathy

NCT03025828

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria

NCT03836144

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinuria, Female Urogenital Diseases, +18 more
Locations: Eurpean Georges Pompidou Hospital Paris, Île-de-France Region, France

View Trial Details

Completed

Empagliflozin in Patients With Glomerulonephritis

NCT05283057

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +10 more
Locations: Cairo university hospitals Cairo, Egypt

View Trial Details

Completed

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

NCT01639339

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: GSK Investigational Site La Palma, California, United States

GSK Investigational Site San Leandro, California, United States

GSK Investigational Site Torrance, California, United States

GSK Investigational Site Gainesville, Florida, United States

View all 118 locations

View Trial Details

Completed

FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

NCT03970122

Conditions: Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, +18 more
Locations: Covance Clinical Research Unit Inc. Dallas, Texas, United States

View Trial Details

Completed

Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

NCT00843856

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Hammersmith Hospital London, United Kingdom

View Trial Details

Completed

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis

NCT03126201

Conditions: Disease Attributes, Disease Progression, Female Urogenital Diseases, +11 more
Locations: Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

NCT00050713

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Dyslipidemias, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

NCT01093157

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +5 more
Locations: University Health Network- Toronto General Hospital Toronto, Ontario, Canada

View Trial Details